Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.68

May 8, 2025 5:21 PM

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.68).

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.